Salter Malcolm

Insider profile

Salter Malcolm's trades of C4 Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-11-18 2024-11-18 PrS Proposed sale
55,040
148.84
US$3,341,663
55,040 148.84 US$3,341,663
2024-10-18 2024-10-18 PrS Proposed sale
82,509
65.56
US$3,242,690
82,509 65.56 US$3,242,690
2024-10-11 2024-10-11 PrS Proposed sale
90,547
239.13
US$3,326,990
90,547 239.13 US$3,326,990
2021-12-17 2021-12-17 PlS Planned sale
755 -6.4%
30.25
US$22,839
755 -6.4% 30.25 US$22,839
2021-11-19 2021-11-19 PlS Planned sale
755 -6.1%
40.11
US$30,283
755 -6.1% 40.11 US$30,283
2021-10-15 2021-10-15 PlS Planned sale
755 -5.7%
44.94
US$33,930
755 -5.7% 44.94 US$33,930
2021-07-19 2021-07-16 PlS Planned sale
755 -5.0%
37.37
US$28,214
755 -5.0% 37.37 US$28,214
2021-06-21 2021-06-18 PlS Planned sale
755 -4.8%
37.19
US$28,078
755 -4.8% 37.19 US$28,078
2021-05-24 2021-05-21 PlS Planned sale
755 -4.6%
37.12
US$28,026
755 -4.6% 37.12 US$28,026
2020-10-06 2020-10-06 B Purchase
1,315 +9.0%
19.00
US$24,985
1,315 +9.0% 19.00 US$24,985